Leukaemia Foundation

Leukaemia, Lymphoma, Myeloma & Related Blood Disorders.

Change Your Location:

Holden

Thanks to Holden’s generous support of our Patient Transport Program, more than 4500 Australian families are able to get to and from hospital for vital treatment each year – free of charge.

The Foundation’s official partnership with Holden began in 2002, following work by racing legend, the late Peter Brock, who helped to establish the Foundation’s Patient Transport Program in 1999.

For Australians with blood cancer, the seemingly simple task of getting to and from treatment can bring with it a host of issues that can add to the burden of being diagnosed.

There’s the stress of driving long distances, or through tedious traffic. Or people have to depend on family and friends to help. Catching public transport can be out of the question because of the higher risk of infection when a person’s immune system is severely weakened.

This is why Holden’s support of the Leukaemia Foundation’s Patient Transport Program means so much. Since 2002, this solid partnership has helped to provide Australians with blood cancer with free, safe and comfortable access to treatment. The vehicles generously provided by Holden are driven by friendly volunteers, who care for the people on board like family.

Each year, Holden generously gives the Leukaemia Foundation 17 new vehicles to use as part of our nationwide Patient Transport Program fleet. In the past six years the fleet – made up mostly of comfy, spacious Commodores – has collectively made more than 118,000 trips and travelled more than five million kilometers. That’s equal to about 126 laps of the globe!

The Leukeamia Foundation provides an enormously valuable service to people with blood cancer and we aim to be able to assist in as many ways as possible. To be able to donate 17 VE Commodores is an important milestone in our 10 year relationship with the Foundation and we are delighted to be assisting the Leukaemia Foundation to further increase their flexibility and patient reach."

Holden Director, Government Relations and Internal Communications, Mr Matt Hobbs